Tissue Sealants Market Size, Share & Industry Analysis, By Product (Synthetic Tissue, Natural Tissue, Others Synthetic Tissue, Natural Tissue, Others), By Application (Urology, Neurology, Pulmonary, Orthopedic, Colorectal, Others), By End User (Research and Academic InstitutesHospitalsSpecialty Clinics and Trauma Centers, Ambulatory surgical Centers, Others) Others and Regional Forecast, 2024-2032

Tissue sealants are the substances used to bind and close damages or defects in the tissues mostly by promoting coagulation cascading. They are widely used in minimally invasive techniques during surgical procedures. Furthermore, tissue sealants help in the reduction of mortality rate occurring due to trauma injuries. For instance, according to the National Trauma Institute, hemorrhage leads to 35% of pre-hospital deaths and over 40% deaths within 24 hours of trauma injuries. In addition to this, they are also frequently used in the treatment of the stomach ulcers, management of blood loss during labor surgeries, and blood vessel rapture. Moreover, various other applications such as bone healing, cartilage repair, renal sparing, otology, and reconstructive surgery are also is fueling the growth of the market during the forecast period.

Key Market Driver -

Rising number of surgical procedures and Trauma injuries.

Key Market Restraint -

stringent regulations, and high cost of the product

Technologically advanced tissue sealants are anticipated to witness wider market growth when compared to traditional techniques of blood clotting, wound closure techniques owing to reduced blood loss surgeries, quick wound healing, quick surgery completion, minimally invasive procedures that eliminate the complication of blood transfusion leading to control in blood reactions. For instance, fibrin sealants can be effectively used to reduce blood loss in total knee replacement surgeries, aortic surgeries, spinal surgeries, cardiovascular surgeries, and others. Additionally, the increase in a number of surgical procedures owing to a rise in sports injuries, accidents, high prevalence of cardiovascular diseases, increase in surgical procedures, are the major driving factors propelling the growth of the market during the course of the period. Furthermore, minimally invasive surgeries, reduction in surgical time, fast recovery, leakage prevention in lap procedures, reduction in length of hospital stay, reduced surgical infections, and others are also triggering the growth of the tissue sealants market.

However, lack of skilled professionals, stringent regulations, high cost of the product are hindering the growth of the tissue sealants market during the forecast period.

Market Segmentation:

Globally, the tissue sealants market is segmented on bases of product type, applications, and end users. Based on the product type, the market is segmented into synthetic tissue and natural tissue. Based on the applications, the market is characterized into urology, neurology, pulmonary, orthopedic, colorectal, and others. Based on the end users, the market is segmented into hospitals, specialty clinics and trauma centers, research and academic centers, ambulatory surgical centers, and others.

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

The major companies in the global tissue sealants market report include Advanced Medical Solutions Group plc, Baxter, Medtronic, Cardinal Health, Smith and Nephew, Johnson & Johnson Services, Inc., Pfizer Inc., Life science corporation Holdings corporation.

Key Insights:

• Number of Surgical Procedures, Key Countries/ Region, 2018


• Pipeline Analysis, Key Players


• New Product Launches


• Technological Advancements of orthopedic treatment


• Key Industry Developments


• Pricing Analysis

Regional Analysis:

To gain extensive insights into the market, Request for Customization

Geographically, the Tissue Sealants market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the market owing to the rise in the number of surgical procedures, an increase in the geriatric population, huge investment in the healthcare industry, and the quick adoption of technology. Europe is the second-largest contributor to the market owing to increased capita income expenditure, increased healthcare infrastructure. Asia Pacific is anticipated to experience vast growth in the market owing to an increase in healthcare awareness, and an increase in government initiatives towards the healthcare sector, and an increase in the number of research activities. Latin America and Middle East are also anticipated to experience lucrative growth in the tissue sealants market.

Segmentation

Tissue Sealants Industry Developments

• In Oct 2018, Baxter launched Tissel, which is fibrin sealant used majorly used as brain sealant with a clinically tested and safety proven by surgeons.


• In 2018, Medtronic launched Veriset patch which helps in achieving faster haemostasis, increased patient safety, and effective in independent clotting ability.


• In SEP 2018, Ethicon launched EVICEL fibrin sealants used in patients undergoing surgeries as adjunct to haemostasis.